本文選題：普羅布考　切入點：腦梗塞　出處：《中國現(xiàn)代醫(yī)學雜志》2017年06期 　論文類型：期刊論文

【摘要】：目的探討普羅布考治療對腦梗塞進展期患者活化部分凝血活酶時間(APTT)、纖維蛋白原及血液流變學的影響,為普羅布考治療腦梗塞的臨床應用提供依據。方法選取2014年1月-2015年1月該院神經內科收治的80例腦梗塞進展期患者為研究對象,隨機分為研究組和對照組,每組40例,對照組采取常規(guī)藥物治療,研究組在對照組基礎上加用普羅布考,比較兩組患者治療前后的APTT、纖維蛋白原及血液流變學的變化。結果研究組的療效與對照組比較,差異統(tǒng)計學意義(P0.05)。研究組患者治療后APTT較治療前延長,且治療后30 d時間較治療后15 d延長。研究組患者治療后APTT與對照組比較,差異有統(tǒng)計學意義(P0.05)。研究組患者治療后纖維蛋白原水平較治療前降低,且治療后30 d水平低于治療后15 d;研究組患者治療后的纖維蛋白原水平與對照組比較,差異有統(tǒng)計學意義(P0.05)。研究組患者治療后的血漿黏度、全血高切黏度及全血低切黏度較治療前均降低,且治療后30 d較治療后15 d降低;研究組患者治療后血漿黏度、全血高切黏度及全血低切黏度與對照組比較,差異有統(tǒng)計學意義(P0.05)。結論普羅布考治療腦梗塞進展期患者療效顯著,能夠延長APTT,降低纖維蛋白原水平,降低血漿黏度、全血高切黏度及全血低切黏度,值得推廣應用。
[Abstract]:Objective to investigate the effect of probucol treatment on cerebral infarction patients with advanced activated partial thromboplastin time (APTT), effects of fibrinogen and blood rheology, provide the basis for clinical application of probucol in treatment of cerebral infarction. Methods from January 2014 -2015 year in January the hospital neurology department treated 80 cases of cerebral infarction patients in advanced stage the object of study, were randomly divided into study group and control group, 40 cases in each group, the control group take routine treatment, the study group compared with the control group were treated with probucol, two groups were compared before and after treatment of APTT, the changes of fibrinogen and blood rheology. Results the study group compared with the control group, the difference was statistically significant (P0.05). To extend the study group after treatment in patients with APTT compared with those before treatment, and the treatment time is 30 d after 15 d after treatment. The study group prolonged after treatment in patients with APTT compared with the control group, the difference was statistically significant (P 0.05). Study on fibrinogen levels than patients in the treatment group after treatment decreased below 30 d and after treatment with 15 d after treatment; group of patients in the study group after treatment of fibrinogen level with the control, the difference was statistically significant (P0.05). The blood viscosity groups after treatment, whole blood high the viscosity and blood viscosity were decreased significantly compared with before treatment, after treatment and 30 d compared to 15 d after treatment decreased; study group patients after plasma viscosity, whole blood viscosity and group compared with the control of blood viscosity, the difference was statistically significant (P0.05). Conclusion probucol treatment in patients with advanced cerebral infarction curative effect obviously, can prolong APTT, reducing the level of fibrinogen, reduce plasma viscosity, whole blood viscosity and blood viscosity, it is worthy of popularization and application.

【作者單位】： 西南醫(yī)科大學附屬醫(yī)院藥劑科;
【分類號】：R743.33

【參考文獻】

相關期刊論文 前10條

1 蔡永強;;補中益氣湯加味聯(lián)合阿托伐他汀治療腦梗塞并高血脂的療效觀察及其對血液流變學的影響[J];中國中醫(yī)藥科技;2016年01期

2 葉長安;;腦梗塞前期患者的腦血流動力學的改變及多排CT灌注成像表現(xiàn)及分期[J];中國CT和MRI雜志;2015年12期

3 李萌生;王曉菲;宋立華;李強強;劉坤;;針灸聯(lián)合西藥治療腦梗塞的療效[J];中西醫(yī)結合心血管病電子雜志;2015年30期

4 吳振宏;歐陽強;梁儉孫;;PAS三聯(lián)療法對老年急性腦梗死患者血清高遷移率族蛋白B1、骨保護素及巨噬細胞移動抑制因子水平的影響[J];中國老年學雜志;2015年03期

5 楊美榮;向海溶;;腦梗死進展期應用低分子肝素鈣與硫酸氯氫吡格雷治療的臨床分析[J];陜西醫(yī)學雜志;2014年12期

6 賈東佩;;降纖酶對腦梗塞急性期患者APTT、PT與血液流變學的影響[J];中國生化藥物雜志;2014年07期

7 陳曉;楊敏;付睿;付研;;瑞舒伐他汀聯(lián)合普羅布考治療頸動脈易損粥樣硬化斑塊的療效臨床隨機對照研究[J];中國全科醫(yī)學;2013年30期

8 馬t熽，

本文編號：1596746